MAPK1 and cancer: There have also been intensive investigations on diverse cancers, where the MAPK/ERK signaling system participates in the proliferation, migration, metastasis and resistance of cancer cells to chemotherapy, which can be triggered by hypoxia and reactive oxygen species-mediated injury and signaling.